Humana (NYSE:HUM) Rating Lowered to Hold at Wall Street Zen

Humana (NYSE:HUM) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Sunday, Wall Street Zen reports.

Several other equities research analysts also recently issued reports on the stock. Citigroup started coverage on shares of Humana in a research note on Friday, October 9th. They issued a “buy” rating on the stock. Evercore upgraded shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 target price for the company in a research note on Wednesday, July 29th. Truist Financial increased their price target on shares of Humana from $415.00 to $475.00 and gave the company a “hold” rating in a report on Monday, October 12th. Monness Crespi & Hardt upgraded shares of Humana to a “buy” rating in a research report on Friday, October 9th. Finally, UBS Group boosted their price objective on shares of Humana from $405.00 to $495.00 and gave the stock a “neutral” rating in a report on Monday, October 12th. Twenty-one research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Humana presently has an average rating of “Moderate Buy” and an average target price of $453.30.

Humana Stock Performance

Shares of NYSE HUM opened at $409.81 on Friday. Humana has a 12 month low of $163.11 and a 12 month high of $456.50. The company has a market cap of $49.21 billion, a P/E ratio of 23.95, a P/E/G ratio of 2.54 and a beta of 0.74. The business’s 50 day moving average is $401.53 and its two-hundred day moving average is $309.38. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62.

Institutional Investors Weigh In On Humana

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Manning & Napier Advisors LLC bought a new stake in shares of Humana during the 2nd quarter worth about $1,412,000. Vista Investment Partners LLC acquired a new position in Humana in the 3rd quarter valued at about $3,254,000. The Manufacturers Life Insurance Company raised its holdings in Humana by 10.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 70,185 shares of the insurance provider’s stock valued at $27,879,000 after acquiring an additional 6,690 shares during the period. Pzena Investment Management LLC bought a new position in Humana in the 2nd quarter valued at about $1,749,014,000. Finally, Ameritas Advisory Services LLC bought a new position in Humana in the 2nd quarter valued at about $1,709,000. 92.38% of the stock is owned by institutional investors and hedge funds.

About Humana

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.